Illustrative

An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses

ACS Publications·Jul 3

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A new vaccine has been developed that provides broad protection against different influenza viruses. The vaccine is administered intranasally and uses a multivalent epitope-based nanoparticle approach. This vaccine may offer protection against divergent influenza viruses.

Full coverage

Influenza mRNA vaccine with engineered panhandle-forming UTRs provides potent, dose-sparing protection against seasonal influenza viruses

Nature·Apr 27

Enhancing the breadth of protection in mice with a multivalent influenza vaccine

Nature·Jan 7

Rational selection of antigenic targets for Group A Streptococcus vaccine: updates, challenges and opportunities

Nature·Apr 17

A Nanoparticle Vaccine Displaying Conserved Epitopes of the Preexisting Neutralizing Antibody Confers Broad Protection against SARS-CoV-2 Variants

ACS Publications·Jun 27

Recent progress in pneumococcal protein vaccines

Frontiers·Feb 10

Self-assembled peptide nanorod vaccine confers protection against influenza A virus

ScienceDirect.com·Jan 11

An Intein-Spliced Nipah G Protein Ferritin Nanoparticle Vaccine Provides Complete Protection against Lethal Nipah Virus Challenge

ACS Publications·Jun 2

Immunoinformatics method to design universal multi-epitope nanoparticle vaccine for TGEV S protein

Nature·Mar 29

View original report at ACS Publications ↗

Fetching the latest headlines…